Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT2051200096
JPRN-jRCT2051200096
Active, not recruiting
Phase 1

ONO-4578-03:Phase 1 study of ONO-4578 given as monotherapy and combinations of ONO-4578 and ONO-4538 as sequential treatment (neoadjuvant therapy) after chemoradiation therapy in subjects with resectable advanced rectal cancer

Hirashima Yoshinori0 sites30 target enrollmentDecember 15, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Hirashima Yoshinori
Enrollment
30
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 15, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hirashima Yoshinori

Eligibility Criteria

Inclusion Criteria

  • •1\. Rectal adenocarcinoma
  • •2\. Patients with ECOG performance status 0 or 1

Exclusion Criteria

  • •1\. Patients with severe complication
  • •2\. Patients with multiple primary cancers

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
ONO-4578-04:ONO-4578 Phase 1 Studymetastatic pancreatic cancer
JPRN-jRCT2031200286Hirashima Yoshinori60
Active, not recruiting
Phase 1
ONO-4578-05:ONO-4578 Phase 1 Studyon-small cell lung cancer
JPRN-jRCT2031200346Osawa Masahiro40
Recruiting
Phase 1
ONO-4578-02:ONO-4578 Phase 1 Studynresectable colorectal cancer
JPRN-jRCT2031200215Hirashima Yoshinori36
Active, not recruiting
Phase 1
ONO-7475-03 : ONO-7475 Phase 1 StudyEGFR mutated, stage IIIB/IIIC/IV or recurrent, NSCLC, which is unsuitable for radical irradiation
JPRN-jRCT2051210045Osawa Masahiro75
Recruiting
Phase 1
ONO-4685-04: ONO-4685 Phase 1 studyAuto immune disease
JPRN-jRCT2071220081Masahiro Osawa72